The impact of the COVID-19 pandemic on the mental health of healthcare workers: study protocol for the COVID-19 HEalth caRe wOrkErS (HEROES) study.


Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 02 04 2021
accepted: 05 12 2021
pubmed: 23 1 2022
medline: 23 3 2022
entrez: 22 1 2022
Statut: ppublish

Résumé

Preliminary country-specific reports suggest that the COVID-19 pandemic has a negative impact on the mental health of the healthcare workforce. In this paper, we summarize the protocol of the COVID-19 HEalth caRe wOrkErS (HEROES) study, an ongoing, global initiative, aimed to describe and track longitudinal trajectories of mental health symptoms and disorders among health care workers at different phases of the pandemic across a wide range of countries in Latin America, Europe, Africa, Middle-East, and Asia. Participants from various settings, including primary care clinics, hospitals, nursing homes, and mental health facilities, are being enrolled. In 26 countries, we are using a similar study design with harmonized measures to capture data on COVID-19 related exposures and variables of interest during two years of follow-up. Exposures include potential stressors related to working in healthcare during the COVID-19 pandemic, as well as sociodemographic and clinical factors. Primary outcomes of interest include mental health variables such as psychological distress, depressive symptoms, and posttraumatic stress disorders. Other domains of interest include potentially mediating or moderating influences such as workplace conditions, trust in the government, and the country's income level. As of August 2021, ~ 34,000 health workers have been recruited. A general characterization of the recruited samples by sociodemographic and workplace variables is presented. Most participating countries have identified several health facilities where they can identify denominators and attain acceptable response rates. Of the 26 countries, 22 are collecting data and 2 plan to start shortly. This is one of the most extensive global studies on the mental health of healthcare workers during the COVID-19 pandemic, including a variety of countries with diverse economic realities and different levels of severity of pandemic and management. Moreover, unlike most previous studies, we included workers (clinical and non-clinical staff) in a wide range of settings.

Sections du résumé

BACKGROUND BACKGROUND
Preliminary country-specific reports suggest that the COVID-19 pandemic has a negative impact on the mental health of the healthcare workforce. In this paper, we summarize the protocol of the COVID-19 HEalth caRe wOrkErS (HEROES) study, an ongoing, global initiative, aimed to describe and track longitudinal trajectories of mental health symptoms and disorders among health care workers at different phases of the pandemic across a wide range of countries in Latin America, Europe, Africa, Middle-East, and Asia.
METHODS METHODS
Participants from various settings, including primary care clinics, hospitals, nursing homes, and mental health facilities, are being enrolled. In 26 countries, we are using a similar study design with harmonized measures to capture data on COVID-19 related exposures and variables of interest during two years of follow-up. Exposures include potential stressors related to working in healthcare during the COVID-19 pandemic, as well as sociodemographic and clinical factors. Primary outcomes of interest include mental health variables such as psychological distress, depressive symptoms, and posttraumatic stress disorders. Other domains of interest include potentially mediating or moderating influences such as workplace conditions, trust in the government, and the country's income level.
RESULTS RESULTS
As of August 2021, ~ 34,000 health workers have been recruited. A general characterization of the recruited samples by sociodemographic and workplace variables is presented. Most participating countries have identified several health facilities where they can identify denominators and attain acceptable response rates. Of the 26 countries, 22 are collecting data and 2 plan to start shortly.
CONCLUSIONS CONCLUSIONS
This is one of the most extensive global studies on the mental health of healthcare workers during the COVID-19 pandemic, including a variety of countries with diverse economic realities and different levels of severity of pandemic and management. Moreover, unlike most previous studies, we included workers (clinical and non-clinical staff) in a wide range of settings.

Identifiants

pubmed: 35064280
doi: 10.1007/s00127-021-02211-9
pii: 10.1007/s00127-021-02211-9
pmc: PMC8782684
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

633-645

Subventions

Organisme : NIMH NIH HHS
ID : R34 MH120179
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Lancet. 2020 Oct 10;396(10257):1102-1124
pubmed: 32941825
Clin Psychol Rev. 2009 Dec;29(8):695-706
pubmed: 19683376
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33758016
Int J Infect Dis. 2021 Jan;102:239-241
pubmed: 33130210
Brain Behav Immun. 2020 Aug;88:901-907
pubmed: 32437915
J Gen Intern Med. 2016 Oct;31(10):1206-11
pubmed: 27170304
Psychol Med. 1997 Jan;27(1):191-7
pubmed: 9122299
Rev Psiquiatr Salud Ment (Engl Ed). 2021 Jun 18;:
pubmed: 34153496
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110062
pubmed: 32771337
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33277297
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Epidemiol Psychiatr Sci. 2020 Dec 17;30:e1
pubmed: 33331255
Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
Psychol Methods. 2013 Jun;18(2):137-50
pubmed: 23379553
J Occup Environ Med. 2018 Mar;60(3):248-257
pubmed: 29252922
Occup Med (Lond). 2020 Jul 17;70(5):317-319
pubmed: 32239155
J Affect Disord. 2021 Dec 1;295:405-409
pubmed: 34507219
J Ment Health. 2015 Feb;24(1):1-3
pubmed: 25587816
Psychiatry Res. 2020 Sep;291:113236
pubmed: 32593853
J Affect Disord. 2021 Jan 1;278:390-394
pubmed: 33007629
Psychol Med. 2020 May 27;:1-3
pubmed: 32456735
J Affect Disord. 2020 Oct 1;275:48-57
pubmed: 32658823
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941

Auteurs

Franco Mascayano (F)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. franco.mascayano@nyspi.columbia.edu.
New York State Psychiatric Institute, New York, NY, USA. franco.mascayano@nyspi.columbia.edu.

Els van der Ven (E)

Department of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit, Amsterdam, The Netherlands.

Maria Francesca Moro (MF)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Università degli Studi di Cagliari, Cagliari, Italy.

Sara Schilling (S)

School of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Sebastián Alarcón (S)

School of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Josleen Al Barathie (J)

Institute for Development Research Advocacy and Applied Care, Beirut, Lebanon.

Lubna Alnasser (L)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Population Health Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Hiroki Asaoka (H)

Department of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Olatunde Ayinde (O)

Department of Psychiatry, University College Hospital, Ibadan, Nigeria.

Arin A Balalian (AA)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

Armando Basagoitia (A)

Consultora Salud Global, Chuquisaca, Bolivia.

Kirsty Brittain (K)

Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Bruce Dohrenwend (B)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

Sol Durand-Arias (S)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico.

Mehmet Eskin (M)

Department of Psychology, Koc University, Istanbul, Turkey.

Eduardo Fernández-Jiménez (E)

Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain.

Marcela Inés Freytes Frey (MI)

Social and Community Academic Unit, Universidad de Chubut, Chubut, Argentina.

Luis Giménez (L)

Instituto de Psicología de la Salud, Facultad de Psicología, Universidad de la República, Montevideo, Uruguay.

Lydia Gisle (L)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Hans W Hoek (HW)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Department of Psychiatry, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

Rodrigo Ezequiel Jaldo (RE)

Social and Community Academic Unit, Universidad de Chubut, Chubut, Argentina.

Jutta Lindert (J)

University of Applied Sciences Emden/Leer, Emden, Germany.

Humberto Maldonado (H)

Dirección de Salud Mental, Ministerio de Salud, Lima, Perú.

Gonzalo Martínez-Alés (G)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain.
Centro de Investigación Biomédica en Red (CIBERSAM), Madrid, Spain.

Carmen Martínez-Viciana (C)

Pan-American Health Organization, Washington, DC, USA.

Roberto Mediavilla (R)

Department of Psychiatry, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Centro de Investigación Biomédica en Red (CIBERSAM), Madrid, Spain.

Clare McCormack (C)

Center for Science and Society, Columbia University, New York, NY, USA.

Landon Myer (L)

Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Javier Narvaez (J)

University of El Bosque, Bogota, Colombia.

Daisuke Nishi (D)

Department of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Uta Ouali (U)

Psychiatry Department A, Razi Hospital, Tunis, Tunisia.

Victor Puac-Polanco (V)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala, Guatemala City, Guatemala.
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Jorge Ramírez (J)

School of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Alexandra Restrepo-Henao (A)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Epidemiology Group, Universidad de Antioquia, Medellín, Colombia.

Eliut Rivera-Segarra (E)

School of Behavioral and Brain Sciences, Ponce Health Sciences University, Ponce, Puerto Rico.

Ana M Rodríguez (AM)

Instituto Altos Estudios Dr Arnoldo Gabaldon, Caracas, Venezuela.

Dahlia Saab (D)

Institute for Development Research Advocacy and Applied Care, Beirut, Lebanon.

Dominika Seblova (D)

Taub Institute for Research on Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, Brazil.

Andrea Tenorio Correia da Silva (A)

Department of Family Medicine, Faculdade Santa Marcelina, São Paulo, Brazil.
Department of Public Health, Faculdade de Medicina de Jundiaí, São Paulo, Brazil.

Linda Valeri (L)

Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.

Rubén Alvarado (R)

School of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Ezra Susser (E)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
New York State Psychiatric Institute, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH